TDAM USA’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $1.76M | Hold |
14,266
| – | – | 0.11% | 131 |
|
|
2021
Q3 | $2.03M | Sell |
14,266
-676
| -5% | -$99.4K | 0.13% | 115 |
|
|
2021
Q2 | $2.37M | Sell |
14,942
-160
| -1% | -$25.9K | 0.15% | 113 |
|
|
2021
Q1 | $2.35M | Sell |
15,102
-319
| -2% | -$49.4K | 0.14% | 125 |
|
|
2020
Q4 | $2.31M | Buy |
15,421
+1,107
| +8% | +$156K | 0.14% | 127 |
|
|
2020
Q3 | $1.89M | Buy |
14,314
+10
| +0.1% | +$1.31K | 0.13% | 128 |
|
|
2020
Q2 | $1.62M | Sell |
14,304
-189
| -1% | -$21.8K | 0.12% | 134 |
|
|
2020
Q1 | $1.42M | Sell |
14,493
-159
| -1% | -$20.8K | 0.12% | 139 |
|
|
2019
Q4 | $2.13M | Sell |
14,652
-2,972
| -17% | -$410K | 0.14% | 134 |
|
|
2019
Q3 | $2.35M | Sell |
17,624
-122
| -0.7% | -$15.8K | 0.17% | 127 |
|
|
2019
Q2 | $2.03M | Sell |
17,746
-787
| -4% | -$92.2K | 0.14% | 126 |
|
|
2019
Q1 | $2.3M | Sell |
18,533
-61
| -0.3% | -$6.93K | 0.16% | 114 |
|
|
2018
Q4 | $1.87M | Sell |
18,594
-725
| -4% | -$81.5K | 0.14% | 121 |
|
|
2018
Q3 | $2.3M | Hold |
19,319
| – | – | 0.14% | 124 |
|
|
2018
Q2 | $2.09M | Buy |
19,319
+381
| +2% | +$41.5K | 0.13% | 128 |
|
|
2018
Q1 | $2M | Sell |
18,938
-499
| -3% | -$58K | 0.12% | 128 |
|
|
2017
Q4 | $2.28M | Sell |
19,437
-419
| -2% | -$47.4K | 0.13% | 123 |
|
|
2017
Q3 | $2.26M | Sell |
19,856
-51,181
| -72% | -$5.91M | 0.13% | 124 |
|
|
2017
Q2 | $8.82M | Sell |
71,037
-53
| -0.1% | -$6.28K | 0.45% | 80 |
|
|
2017
Q1 | $8.43M | Sell |
71,090
-505
| -0.7% | -$57.2K | 0.43% | 79 |
|
|
2016
Q4 | $7.17M | Sell |
71,595
-2,861
| -4% | -$307K | 0.38% | 87 |
|
|
2016
Q3 | $9.4M | Sell |
74,456
-287
| -0.4% | -$35.5K | 0.47% | 72 |
|
|
2016
Q2 | $8.73M | Sell |
74,743
-1,202
| -2% | -$136K | 0.43% | 78 |
|
|
2016
Q1 | $7.86M | Sell |
75,945
-3,569
| -4% | -$345K | 0.38% | 84 |
|
|
2015
Q4 | $7.92M | Sell |
79,514
-6,945
| -8% | -$680K | 0.38% | 82 |
|
|
2015
Q3 | $7.88M | Sell |
86,459
-471
| -0.5% | -$47.2K | 0.4% | 80 |
|
|
2015
Q2 | $9.22M | Sell |
86,930
-1,385
| -2% | -$153K | 0.42% | 79 |
|
|
2015
Q1 | $10.1M | Sell |
88,315
-4,005
| -4% | -$457K | 0.41% | 82 |
|
|
2014
Q4 | $10.2M | Sell |
92,320
-1,083
| -1% | -$114K | 0.43% | 83 |
|
|
2014
Q3 | $9.12M | Sell |
93,403
-3,321
| -3% | -$327K | 0.39% | 85 |
|
|
2014
Q2 | $9.75M | Sell |
96,724
-2,363
| -2% | -$231K | 0.41% | 87 |
|
|
2014
Q1 | $9.1M | Sell |
99,087
-19,871
| -17% | -$1.83M | 0.4% | 86 |
|
|
2013
Q4 | $10.8M | Buy |
118,958
+43,845
| +58% | +$3.79M | 0.46% | 72 |
|
|
2013
Q3 | $5.99M | Sell |
75,113
-58,628
| -44% | -$4.62M | 0.28% | 90 |
|
|
2013
Q2 | $10.2M | Buy |
+133,741
| New | +$10M | 0.47% | 68 |
|
Other funds holding ZBH
TDAM USA's ZBH Position: Q4 2021 in Review
TDAM USA held its Zimmer Biomet (ZBH) position steady in Q4 2021 at 14,266 shares worth $1.76M. The position accounts for 0.11% of the portfolio, ranked #131.
TDAM USA first reported a position in ZBH in Q2 2013 and has held it in 35 quarters since. The position peaked at $10.8M in Q4 2013. 999 funds tracked by Wall St. Rank hold ZBH as of Q4 2021.
- TDAM USA held 14,266 shares of Zimmer Biomet worth $1.76M as of Q4 2021.
- TDAM USA left its Zimmer Biomet share count unchanged in Q4 2021.
- Zimmer Biomet made up 0.11% of TDAM USA's portfolio in Q4 2021, its #131 holding.
- TDAM USA first reported a position in Zimmer Biomet in Q2 2013 and has held it in 35 quarters since.
- TDAM USA's Zimmer Biomet position peaked at $10.8M in Q4 2013.
- 999 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2021.
Based on TDAM USA's 13F filing for Q4 2021, filed 10 Feb 2022.